StreetAlpha.app
Home › Stocks › LFMD

LifeMD, Inc. (LFMD)

Healthcare
$1.45
▼ −9.40%
LAST CLOSE · NOV 20

LifeMD provides virtual primary care and prescription services to patients through its telehealth platform and affiliated pharmacy. It last closed at $1.45 on Nov 20, down 9.40% on the day. The next earnings report for LFMD is expected around Mon, Mar 8, 2027, after the close. For the quarter ended Sep 2026, LFMD reported EPS of -$0.11 on revenue of $44.6M, with revenue down 6.5% from a year ago. Over its last 8 reports the stock moved an average of 21.6% the session after earnings. Over the last 12 months LFMD insiders bought $0 of stock on the open market and sold $54K, according to SEC Form 4 filings.

AI Auto Pilots
Is LFMD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LFMD.

Key Stats

Last 12 months
Results
Revenue
$189.2M
+24.2% vs a year ago
Net income
$242K
0.1% margin
EPS (diluted)
−$0.03
Free cash flow
−$11.2M
−5.9% margin
Valuation
Market cap
$69.8M
48.3M shares
P/E
–
No P/E while losing money
Price to sales
0.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$21.9M
At Sep 30
Shareholder equity
−$580K
Shares outstanding
48.3M
At Nov 11
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $92.9M$92.9MFY2021FY2022: $119.0M$119.0MFY2022FY2023: $152.5M$152.5MFY2023FY2024: $154.8M$154.8MFY2024FY2025: $194.1M$194.1MFY2025

From LFMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Mar 8
Estimated date · After the close
Reported EPS
-$0.11
Quarter ended Sep 2026
Year ago EPS
-$0.10
Same quarter last year
Revenue
$44.6M
−6.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.14Dec '24Mar 2025: -$0.02Mar '25Jun 2025: -$0.05Jun '25Sep 2025: -$0.10Sep '25Dec 2025: $0.45Dec '25Mar 2026: -$0.20Mar '26Jun 2026: -$0.16Jun '26Sep 2026: -$0.11Sep '26Latest -$0.11
Revenue by quarter
Dec 2024: $5.5MDec '24Mar 2025: $50.9MMar '25Jun 2025: $49.0MJun '25Sep 2025: $47.7MSep '25Dec 2025: $47.2MDec '25Mar 2026: $50.2MMar '26Jun 2026: $47.3MJun '26Sep 2026: $44.6MSep '26Latest $44.6M
How LFMD moved after its last 8 reports
Average move the session after a report ±21.6%
Nov 12, 2026After the close+32.6%
Aug 5, 2026After the close−7.6%
May 6, 2026After the close−14.8%
Mar 9, 2026After the close+25.3%
Nov 17, 2025After the close−13.5%
Aug 5, 2025After the close−44.9%
May 6, 2025After the close+3.2%
Mar 10, 2025After the close+30.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on LFMDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on LFMD
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on LFMD

Technical Analysis

LFMD · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 40% below its 20 day and 71% below its 50 day average. It is 146% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the 52 week low at $1.38, and the nearest resistance the Pivot at $1.47.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 15.7%/day
Key levels
$5.3852 week high+271.0%
$3.56200 day average+145.5%
$3.08100 day average+112.4%
$2.4750 day average+70.3%
$2.34Swing high (Nov 13)+61.4%
$2.0220 day average+39.3%
$1.56Pivot R1+7.6%
$1.47Pivot+1.4%
$1.45Last close
$1.3852 week low−4.8%
$1.36Pivot S1−6.2%
Indicators
RSI (14)33.17Weak, oversold below 30Neutral
MACD-0.24Below its signal lineBearish
Stochastic7.9Near the bottom of its rangeOversold
ADX (14)30.2Trending down
Williams %R-94.2Oversold below −80, overbought above −20Oversold
CCI (20)-152.2Oversold below −100, overbought above 100Oversold
Rate of change−39.0%Change over 10 sessionsBearish
ATR (14)$0.23Typical daily range, 15.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for LFMD

What happened before

See how LFMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow LFMD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How LFMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for LFMDHow many large options trades hit LFMD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

LFMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼31 buying vs 75 selling
  • ▼Held by funds -4.8 pts
  • ▼Funds holding -23
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding94117−19.7%
In funds' top 1001−100.0%
Held by funds40.1%44.9%−4.8 pts
New / increased9 / 2225 / 46−56.3%
Reduced / sold out42 / 3325 / 11+108.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LFMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

LFMD Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$54K1 sale · 1 insider
2025-12 sold $54KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Dec 9, 2025Jessica FriedemanChief Marketing OfficerSale15,000$3.61$54K
Sep 10, 2025Nicholas P AlvarezChief Acquisition OfficerSale75,000$5.92$444K
Jul 1, 2025Justin SchreiberChairman and CEOSale plan25,000$9.99$250K
Jul 1, 2025Justin SchreiberChairman and CEOSale plan25,000$13.38$335K
Jun 17, 2025Marc David BenathenCFOSale plan125,000$13.46$1.7M
Jun 13, 2025Stefan GalluppiChief Innovation OfficerSale plan85,000$12.38$1.1M
Every insider buy and sale for LFMD over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See LFMD insider trades →

From SEC Form 4 filings by LFMD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LFMD is in one of them and how their past LFMD trades turned out.

LFMD in the AI portfolios
Loading…

LFMD News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LFMD in an article yet. Here's the latest on the wider market.

LFMD in the news

About LifeMD

LifeMD is a virtual healthcare company based in New York that provides primary care and specialty medical services to patients through online consultations. Its services cover areas such as weight management, women's health, behavioral health, and dermatology, with prescriptions filled through its own affiliated pharmacy and a network of licensed physicians and nurse practitioners. Most of its revenue comes from subscription plans, and its customers are individual patients across the United States.

Headquarters
New York, NY